Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (381-390 of 394) with videos related to

Pageof 40
Sort By:
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
The Journal of Infectious Diseases|May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesMing-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Nature Communications|July 2, 2025
Single-cell signaling network profiling during redox stress reveals dynamic redox regulation in immune cellsYi-Chuan Wang, Ping-Hsun Wu, Wen-Chieh Ting, et al.
Pageof 40

Showing results (381-390 of 394) with videos related to

Sort By:
Pageof 40
The American Journal of Gastroenterology|January 31, 2023
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 8, 2024
Correction to: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis BHannah S J Choi, Grishma Hirode, Chien-Hung Chen, et al.
The American Journal of Gastroenterology|March 14, 2024
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)Grishma Hirode, Bettina E Hansen, Chien-Hung Chen, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
The Journal of Infectious Diseases|May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesMing-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Nature Communications|July 2, 2025
Single-cell signaling network profiling during redox stress reveals dynamic redox regulation in immune cellsYi-Chuan Wang, Ping-Hsun Wu, Wen-Chieh Ting, et al.
Pageof 40